Yoshimoto A, Johdo O, Ishikura T, Takeuchi T
Central Research Laboratories, Mercian Corporation, Kanagawa, Japan.
Jpn J Antibiot. 1991 Mar;44(3):277-86.
Anthracycline antibiotics 2-hydroxyaclacinomycins A and B were isolated and purified from the culture broth of a recombinant strain which was produced by protoplast fusion of two aclacinomycin-blocked mutants. 2-Hydroxyaclacinomycin B is a new compound for which chemical structure and the biological activity in vitro were determined. 2-Hydroxyaclacinomycins had a stronger antitumor activity against murine leukemic L1210 cells in mice than the parent antibiotic aclacinomycins.